Приказ основних података о документу

dc.creatorRužić, Dušan
dc.creatorĐoković, Nemanja
dc.creatorPetković, Miloš
dc.creatorGul, Sheraz
dc.creatorLahtela‐Kakkonen, Maija
dc.creatorGanesan, A.
dc.creatorSrdić-Rajić, Tatjana
dc.creatorNikolić, Katarina
dc.date.accessioned2023-06-01T10:25:29Z
dc.date.available2023-06-01T10:25:29Z
dc.date.issued2022
dc.identifier.urihttps://farfar.pharmacy.bg.ac.rs/handle/123456789/4763
dc.language.isoensr
dc.publisherEuropean Federation for Medicinal Chemistry and Chemical Biology (EFMC)sr
dc.publisherSociété de Chimie Thérapeutique (SCT)sr
dc.relationinfo:eu-repo/grantAgreement/MESTD/inst-2020/200161/RS//sr
dc.rightsrestrictedAccesssr
dc.sourceEFMC-ISMC, XXVII EFMC International Symposium on Medicinal Chemistry, Book of Abstractssr
dc.titleRational design and in vitro evaluation of selective inhibitors of cytoplasmic histone deacetylases SIRT2 and HDAC6sr
dc.typeconferenceObjectsr
dc.rights.licenseARRsr
dc.citation.spage141
dc.citation.epage141
dc.description.otherXXVII EFMC International Symposium on Medicinal Chemistry, Nice, France, September 4-8, 2022sr
dc.identifier.rcubhttps://hdl.handle.net/21.15107/rcub_farfar_4763
dc.type.versionpublishedVersionsr


Документи

Thumbnail

Овај документ се појављује у следећим колекцијама

Приказ основних података о документу